<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR24">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Advani</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Coiffier</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Czuczman</surname>
    <given-names>MS</given-names>
   </name>
   <name>
    <surname>Dreyling</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Foran</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Gine</surname>
    <given-names>E</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study</article-title>
  <source>J Clin Oncol</source>
  <year>2010</year>
  <volume>28</volume>
  <fpage>2085</fpage>
  <lpage>2093</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2009.25.1900</pub-id>
  <?supplied-pmid 20308665?>
  <pub-id pub-id-type="pmid">20308665</pub-id>
 </element-citation>
</ref>
